Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Genliang Liu"'
Autor:
Ying Yang, Min Shi, Xiaodan Liu, Qiaoyun Zhu, Zhi Xu, Genliang Liu, Tao Feng, Tessandra Stewart, Jing Zhang
Publikováno v:
Journal of Advanced Research, Vol 62, Iss , Pp 187-198 (2024)
Introduction: Morphological abnormalities of erythrocytes/red blood cells (RBCs), e.g., increased acanthocytes, in Parkinson’s disease (PD) have been reported previously, although the underlying mechanisms remain to be characterized. In this study,
Externí odkaz:
https://doaj.org/article/04bdc3721bac468fb171f27d9d49a03a
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionThe differentiation between essential tremor (ET) and Parkinson’s disease (PD) can be difficult because of the symptom overlaps. Erythrocytes are the major source of peripheral α-synuclein (α-syn), which is the most studied pathologic
Externí odkaz:
https://doaj.org/article/5dff117ea4f141de9854ce6e4b752bd3
Autor:
Xiaodan Liu, Qilong Wang, Ying Yang, Tessandra Stewart, Min Shi, David Soltys, Genliang Liu, Eric Thorland, Eugene M. Cilento, Yiran Hou, Zongran Liu, Tao Feng, Jing Zhang
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-16 (2021)
Abstract Peripheral biomarkers indicative of brain pathology are critically needed for early detection of Parkinson’s disease (PD). In this study, using NanoString and digital PCR technologies, we began by screening for alterations in genes associa
Externí odkaz:
https://doaj.org/article/41c984c6fe284c118d8bd3d876168c3a
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
BackgroundErythrocytes contain most of the peripheral α-synuclein (α-syn), which is the key pathological molecular of α-synucleinopathies including Parkinson’s disease (PD). Our objectives were to assess the efficiency of erythrocytic total and
Externí odkaz:
https://doaj.org/article/6473c2de80aa4147b6494c59cc894ba0
Autor:
Chen Tian, Genliang Liu, Liyan Gao, David Soltys, Catherine Pan, Tessandra Stewart, Min Shi, Zhiying Xie, Na Liu, Tao Feng, Jing Zhang
Publikováno v:
Translational Neurodegeneration, Vol 8, Iss 1, Pp 1-12 (2019)
Abstract Background Erythrocytes are a major source of peripheral α-synuclein (α-Syn). The goal of the current investigation is to evaluate erythrocytic total, oligomeric/aggregated, and phosphorylated α-Syn species as biomarkers of Parkinson’s
Externí odkaz:
https://doaj.org/article/dbd181490c804d48900cb33fe198bd8a
Autor:
Xuemei Wang, Zhentang Cao, Genliang Liu, Zhu Liu, Ying Jiang, Huizi Ma, Zhan Wang, Yaqin Yang, Huimin Chen, Tao Feng
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background and Objective: Parkinson's disease developed from essential tremor (ET-PD) is a distinct clinical syndrome that is different from essential tremor (ET) and Parkinson's disease (PD). There is currently a lack of research on ET-PD. Tremor ch
Externí odkaz:
https://doaj.org/article/2890e23b18bf46f3ac4ee701261d766f
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background and aim: Discriminating multiple system atrophy-parkinsonism (MSA-P) from Parkinson's disease (PD) is challenging. We aimed to provide a new method to make an identification between MSA-P and PD by combining biofluid marker with electrophy
Externí odkaz:
https://doaj.org/article/0c73a45728e840b6874834f1139230ac
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
In the storeroom C7 of the Tianjin Museum, one wooden desk and two leather luggages dated back to Qing dynasty (1644-1912 AD) presented viable microbial contamination. The aim of the present study was to investigate microbial communities responsible
Externí odkaz:
https://doaj.org/article/b267d99246cb4ac183e1f02da7260f11
Publikováno v:
Parkinsonism & Related Disorders. 104:44-48
Early diagnosis of Parkinson's disease (PD) could significantly improve outcomes for patients and future disease-modifying treatments. Several studies have revealed that α-synuclein levels in peripheral erythrocytes are associated with PD, but the d
Publikováno v:
Neurological Sciences. 43:5343-5353
Introduction Emerging evidence has suggested that lipid metabolism is correlated with Parkinson’s disease (PD) onset and progression. However, the effect of lipid metabolism on motor performance in PD patients is still unknown. This study estimated